Equities
Health CareHealth Care Providers
  • Price (USD)295.17
  • Today's Change1.20 / 0.41%
  • Shares traded523.64k
  • 1 Year change-41.79%
  • Beta0.5201
Data delayed at least 15 minutes, as of Nov 21 2024 16:51 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Humana Inc had net income fall -11.30% from 2.81bn to 2.49bn despite a 14.54% increase in revenues from 92.87bn to 106.37bn.
Gross margin--
Net profit margin1.25%
Operating margin2.40%
Return on assets2.72%
Return on equity7.88%
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at Humana Inc fell by 367.00m. However, the company earned 3.98bn from its operations for a Cash Flow Margin of 3.74%. In addition the company used 3.49bn on investing activities and also paid 856.00m in financing cash flows.
Cash flow per share19.82
Price/Cash flow per share14.72
Book value per share145.88
Tangible book value per share52.53
More ▼

Balance sheet in USDView more

Humana Inc has a Debt to Total Capital ratio of 42.49%, a lower figure than the previous year's 55.95%.
Current ratio--
Quick ratio--
Total debt/total equity0.7414
Total debt/total capital0.4249
More ▼

Growth rates in USD

Year on year, growth in dividends per share increased 12.38% while earnings per share excluding extraordinary items fell by -9.41%. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.66%
Div growth rate (5 year)13.25%
Payout ratio (TTM)31.79%
EPS growth(5 years)9.96
EPS (TTM) vs
TTM 1 year ago
-53.18
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.